Validation of a flow cytometric acridine orange micronuclei methodology in rats

K A Criswell1, G Krishna, D Zielinski

  • 1Drug Safety Evaluation, Pfizer Global Research and Development, Ann Arbor Laboratories, Ann Arbor, MI 48105, USA. kay.criswell@pfizer.com

Mutation Research
|July 23, 2003
PubMed

Related Concept Videos